SPDR S&P Biotech ETF
Health/Biotechnology
XBI
One Iron Street,
Boston , MA, 02210
Boston , MA, 02210
Price
-
$ 91.28
0 %
+1.47
Dec 20, 2024
- Last Close
- Net Assets
-
$7B
Feb 27, 2024
- 52-Week High/Low
- $104.18 - $82.22
- Expense Ratio
- -
Link
Directors
Sep 12, 2023- Sandra G. Sponem
- Dwight D. Churchill
- Gunjan Chauhan
- Carolyn M. Clancy
- Carl G. Verboncoeur
- James E. Ross
- Clare S. Richer
- Kristi L. Rowsell
Chief Compliance Officer
- Brian Harris
Company Name |
Holding |
| More | 0.1 % |
Documents
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | 6.3% | -8.2% | -19.7% | -3.6% | -18.6% | 26.2% |
| Q2 | -2.4% | 9.2% | -17.4% | -0.2% | 44.6% | -3% |
| Q3 | - | -12.2% | 6.8% | -7.2% | -0.6% | -13.6% |
| Q4 | - | 26.4% | 4.6% | -10.9% | 26.5% | 24.7% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.1% | 12.6% | -3.6% | -10.8% | 5.1% | - | - | - | - | - | - | - |
| 2023 | 7.1% | -6.8% | -8% | 5.2% | 4.6% | -0.9% | 1.3% | -6% | -7.8% | -9.3% | 14% | 18.2% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.4% | 7.6% | -25.9% | -20.4% | 48% | 32.6% | -15.3% | 43.8% | -15.4% | 13.6% | 45% |